Specialty Drug Spending in 2018 Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
5. FDA Approves Two Fixed Dose HIV Treatments
New combination therapy gains approval for adult and pediatric patients with HIV-1.
4. Castration-Sensitive Prostate Cancer Drug Gets FDA Greenlight
FDA expands the indication of abiraterone acetate (Zytiga) to include more patients with prostate cancer.
3. Top 3 Legislative Priorities for Pharmacists
Direct and indirect remuneration fees remain a top concern for pharmacists in 2018.
2. Personalized Medicine Approvals Continued to Surge in 2017
Thirty-five percent of drug approvals in 2017 were personalized drugs.
1. Top 8 Specialty Drug Categories Driving Spending in 2018
Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Effectively Managing Immunizations in the Long-Term Care SettingSeptember 18th 2025
Creating a Culture of Quality in Fast-Melt Tablet DevelopmentSeptember 18th 2025
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
